✦ LIBER ✦

Disability outcomes and dose escalation with etanercept, adalimumab, and infliximab in rheumatoid arthritis patients: a US-based retrospective comparative effectiveness study

✍ Scribed by Schabert, V.F.; Bruce, B.; Ferrufino, C.F.; Globe, D.R.; Harrison, D.J.; Lingala, B.; Fries, J.F.

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

A comparative effectiveness study of ada

✍ Greenberg, J. D.; Reed, G.; Decktor, D.; Harrold, L.; Furst, D.; Gibofsky, A.; D 📂 Article 📅 2012 🏛 BMJ Publishing Group 🌐 English ⚖ 200 KB

PMS2 DISABILITY OUTCOMES AND DOSE ESCALA

✍ VF Schabert; B Bruce; CP Ferrufino; JF Fries; D Globe; DJ Harrison 📂 Article 📅 2010 🏛 John Wiley and Sons 🌐 English ⚖ 75 KB

Efficacy of treatment intensification wi

✍ Eng, Grith; Stoltenberg, Michael B.; Szkudlarek, Marcin; Bouchelouche, Pierre N. 📂 Article 📅 2013 🏛 Elsevier Science 🌐 English ⚖ 286 KB

Use of tumor necrosis factor-α (TNF-α) a

✍ Sophia Li; Primal P. Kaur; Virginia Chan; Steven Berney 📂 Article 📅 2009 🏛 Springer 🌐 English ⚖ 102 KB

Comparative effectiveness and survival o

✍ Flouri, Irini; Markatseli, Theodora E.; Voulgari, Paraskevi V.; Boki, Kyriaki A. 📂 Article 📅 2014 🏛 Elsevier Science 🌐 English ⚖ 696 KB

Safety and effectiveness of switching fr

✍ Koike, Takao; Harigai, Masayoshi; Inokuma, Shigeko; Ishiguro, Naoki; Ryu, Junnos 📂 Article 📅 2011 🏛 Springer 🌐 English ⚖ 272 KB